« Zurück
Startseite /
COVID-19 Spike-ACE2 Binding Assay Kit

COVID-19 Spike-ACE2 Binding Assay Kit

ArtNr	CoV-ACE2S2-2
Hersteller	Raybiotech
Menge	2 Plate Kit
Quantity options	1 Plate Kit 2 Plate Kit 5 Plate Kit 1 Plate Kit 2 Plate Kit 5 Plate Kit
Kategorie	Infectious Diseases Viral Infections Coronavirus (COVID-19) Other Assays & Kits Other Kits Functional Assay
Typ	Assay-Kit
Specific against	Human (Homo sapiens), SARS-CoV-2
Host	Hamster - Armenian
ECLASS 10.1	32161090
ECLASS 11.0	32161090
UNSPSC	41116126
Versandbedingung	Gekühlt
Lieferbar
Manufacturer - Category	COVID-19\|Binding Assays\|ELISA Kits\|Ligand Binding Assays
Manufacturer - Targets	ACE-2, Spike Protein
Shipping Temperature	Blue ice
Storage Conditions	4°C
Description	The RayBio® COVID-19 Spike-ACE2 binding assay kit is a patented, rapid, simple, and sensitive method to characterize the binding affinity of the SARS-CoV-2 Spike (S) protein and the Angiotensin I Converting Enzyme 2 (ACE2) receptor complex in the presence of potential inhibitors. Positive and negative controls for the Spike-ACE2 binding assays are available as an accessory item. Click here.
Compatible Sample Types	Plasma, Serum, Antibodies, Proteins, Small Molecules, Peptides
Method of Detection	Colorimetric
Quantitative/Semi-Quantitative	Semi-Quantitative
Solid Support	96-well Microplate
Gene Symbols	ACE2, S, RBD, SRBD, S-RBD
UNSPSC Code	41116133
Protein Name & Synonyms	Angiotensin-converting enzyme 2, ACE-related carboxypeptidase, Angiotensin-converting enzyme homolog, ACEH, Metalloprotease MPROT15, Processed angiotensin-converting enzyme 2, ACE2, Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD)
Note	The binding assay comes in two different options based on which protein is immobilized on the plate and which protein is added in solution (i.e. "query"). It is the researcher's responsibility to select the format for their study.
Inhibition of Spike-ACE2 by anti-viral compounds	Four small molecules tested for neutralizing activity with COVID-19 Spike-ACE2 Binding Assay (COV-SACE2).
Inhibition of Spike-ACE2 by anti-Spike antibodies	Four antibodies tested for neutralizing activity with COVID-19 Spike-ACE2 Binding Assay (COV-SACE2). nAb 1 = 130-10807 nAb 2 = 130-10844 nAb 3 = 130-10845 negative control = 130-10813.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

CoV-ACE2S2-2.pdf

CoV-ACE2S2-2-datasheet.pdf

CoV-ACE2S2-2-safety-datasheet.pdf